medigraphic.com
ISSN 1028-4818 (Electronic)

2022, Number 2

<< Back Next >>

Mul Med 2022; 26 (2)

Antigens of the ABO system and clinical manifestations of Covid-19 in a health area of ​​the Bayamo municipality

Cruz MEF, Hernández GJM, Fonseca GRL, Sarduy RA, Milanés OMR

Language: Spanish
References: 20
Page:
PDF size: 229.11 Kb.


ABSTRACT

Introduction: A plethora of symptoms/signs have been described that clearly indicate that COVID-19 is a complex disease, and a growing number of reports have suggested that ABO blood groups are related to the risk of developing the disease.
Objective: to identify if there is a relationship between the blood phenotypes of the ABO system and the clinical manifestations of Covid-19 in a health area in the Bayamo municipality.
Methods: a retrospective descriptive study was carried out, which included 123 confirmed COVID-19 patients with epidemiological discharge. Blood group was determined according to the ABO system. The subjects were classified according to the number of symptoms/signs, the predominance of respiratory symptoms/signs or not. The association between the blood groups of the ABO system, the carriers of the different antigens in comparison with those of those without the antigen and the groups by number of symptoms and signs, and according to predominance or not of respiratory symptoms/signs was analyzed.
Results: a significant association was found between the blood group of the patients and the groups according to the number of symptoms/signs presented, as well as between carriers of B and non-B antigens and the groups according to the number of symptoms/signs presented and the predominance of respiratory symptoms or not, in all cases with a higher frequency of patients with phenotype A.
Conclusions: it is concluded that in this study the blood group of patients positive for Covid-19 was related to the number of symptoms/signs presented, with a predominance of the frequency of carriers of antigen A over the others.


REFERENCES

  1. Pérez Abreu MR, Gómez Tejeda JJ, Dieguez Guach RA. Características clínico-epidemiológicas de la COVID-19. Rev haban cienc méd. 2020; 19(2): e3254.

  2. Roblejo Balbuena H, Benítez Cordero Y, Álvarez Gavilán Y, Bravo Ramírez M, Pereira Roche N, García Gómez D, et. al. Características clínico-epidemiológicas de pacientes cubanos residentes en La Habana afectados por la COVID-19. Rev Cubana Investig Bio. 2021; 40(4): e1566.

  3. Dashboard Cuba: Covid19cubadata. [Internet]. 2021 [citado 27/08/2021]. Disponible en: https://covid19cubadata.github.io/#cuba3. .

  4. Romo Domínguez KJ, Saucedo Rodríguez EG, Hinojosa Maya S, Mercado Rodríguez JY, Uc Rosaldo JE, Ochoa García E, et al. Manifestaciones clínicas de la COVID-19. Rev Latin Infect Pediatr. 2020; 33(s1): s10-s32.

  5. Fernández Botrán R. Asociación del grupo sanguíneo ABO con susceptibilidad a COVID-19. Ciencia, Tecnología y Salud. 2020; 7(3): 325 - 32.

  6. Peña García Y, Suárez Padilla A, Arruebarrena Blanco NM. Caracterización de casos positivos y sospechosos de COVID-19 con comorbilidades. Revista Finlay. 2020; 10(3):314-9.

  7. Zhang Y, Garner R, Salehi S, La Rocca M, Duncan D. Association between ABO blood types and coronavirus disease 2019 (COVID-19), genetic associations, and underlying molecular mechanisms: a literature review of 23 studies. Annals of Hematology. 2021; 100(5): 1123_32.

  8. Pendu JL, Breiman A, Rocher J, Dion M, Ruvoën Clouet N. ABO Blood Types and COVID-19: Spurious, Anecdotal, or Truly Important Relationships? A Reasoned Review of Available Data. Viruses 2021; 13(2): 160-80.

  9. Fan Q, Zhang W, Li B, Li DJ, Zhang J, Zhao F. Association Between ABO Blood Group System and COVID-19 Susceptibility in Wuhan. Front Cell Infect Microbial . 2020; 10:404.

  10. Gupta A, Madhavan MV, Sehga K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020; 26(7): 1017-32.

  11. Deleers M, Breiman A, Daubie V, Maggetto C, Barreau I, Besse T, et al. Covid-19 and blood groups: ABO antibody levels may also matter. Int. J. Infect. Dis. 2021; 104: 250-4

  12. Sebastian Kamps B, Hoffmann C. COVID Reference [Internet]. Hamburg: Steinhäuser Verlag; 2021. [citado 5/4/2022]. Disponible en: https://amedeo.com/CovidReference06.pdf12. .

  13. Government of Canada. Coronavirus disease (COVID-19). COVID-19 signs, symptoms and severity of disease: A clinician guide. [Internet]. Canadad: Government of Canada; 2021. [citado 28/08/2021]. Disponible en: https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/guidance-documents/signs-symptoms-severity.html13. .

  14. National Institutes of Health. COVID-19 Treatment Guidelines. Clinical Spectrum of SARS-CoV-2 Infection [Internet].Estados Unidos: NIH; 2021. [citado 30/08/2021]. Disponible en: https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/14. .

  15. Juventud Rebelde. La herencia roja. Sección Opinión. Juventud Rebelde. [Internet] 1/08/2009. [citado 5/04/2022]. Disponible en: http://www.juventudrebelde.cu/cuba/2009-08-01/la-herencia-roja15. .

  16. Nalbant A, Aydin A, Yaylaci S, Kaya T, Wermeulen CL, Cinemre H. Association of ABO blood group and age with COVID-19 positive test. Rev Assoc Med Bras. 2021; 67(Suppl 1):46-50

  17. Dzik S, Eliason K, Morris EB, Kaufman RM, North CM. COVID-19 and ABO blood groups. Transfusion. 2020; 60(8):1883-4.

  18. Li J, Wang X, Chen J, Cai Y, Deng A, Yang M. Association between ABO blood groups and risk of SARS-CoV-2 pneumonia. Brit J Haematol. 2020; 190(1): 24-7.

  19. Silva Filho JC, Farias de Melo CG, Lima de Oliveira J. The influence of ABO blood groups on COVID-19 susceptibility and severity: a molecular hypothesis based on carbohydrate-carbohydrate interactions. Med Hypotheses. 2020; 144:110155.

  20. Gérard C, Maggipinto G, Minon JM. COVID-19 and ABO blood group: another viewpoint. Br J Haematol 2020; 190(2): e93-e4.




2020     |     www.medigraphic.com